Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Compounded Medications and Probiotics for Irritable Bowel Syndrome

Author(s):  Narváez Katherine Rivera, Thompson Tara

Issue:  Sep/Oct 2022 - Volume 26, Number 5
View All Articles in Issue

Abstract:  Studies have found that the microflora composition of individuals with irritable bowel syndrome and ulcerative colitis differ from those of healthy individuals. Some findings suggest a decrease in beneficial bacteria populations and an increase in pathogenic bacteria populations or a higher abundance of bacteria overall (known as small intestinal bacterial overgrowth in these populations). Pharmaceutical compounders are able to formulate medications that are not available commercially that may provide a more targeted therapy for the treatment of irritable bowel syndrome or ulcerative colitis, or they can provide doses that may otherwise be difficult to achieve with commercially available products. This article discusses these two maladies and the important role of pharmaceutical compounding in their treatment options.

Related Keywords: Katherine Rivera Narvaez, PharmD, Tara Thompson, PharmD, irritable bowel syndrome, IBS, ulcerative colitis, inflammation, inflammatory bowel disease, probiotics, prebiotics, gut microflora, gastrointestinal microflora, small intestinal bacterial overgrowth, naltrexone, amitriptyline, sodium butyrate, nifedipine, diltiazem, short-chain fatty acids, erythromycin, mesalamine, probiotic vehicle, formulation, tacrolimus

Related Categories: FORMULATIONS, GASTROENTEROLOGY, ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version




Download in electronic PDF format for $55

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Compounded Medications and Probiotics for Irritable Bowel Syndrome Narváez Katherine Rivera, Thompson Tara Sep/Oct 2022 378-384 Buy
Probiotics and Their Effect on Leaky Gut Syndrome and Associated Diseases Hinze John, Mahan Tracy Sep/Oct 2000 349 Buy
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Ploesser Jennifer, Weinstock Leonard B, Thomas Erin Mar/Apr 2010 171-173 Buy
Probiotic Therapy, Part 2: Clinical Perspectives Vail Jane May/Jun 2006 195-200 Buy
The Treatment of Canine Atopic Disease Davidson Gigi S May/Jun 2002 210-215 Buy
Basics of Compounding for Raynaud's Disease Glasnapp Andrew Jul/Aug 2003 288-291 Buy
Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives Vail Jane Mar/Apr 2006 107-111 Buy
Treating Canine Hepatic Disease Davidson Gigi S May/Jun 2003 188-191 Buy
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease McElhiney Linda F Sep/Oct 2013 380-383 Buy
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi Jul/Aug 2015 295-300 Buy